If you can still get excited about diabetes research headlines, then here’s some exciting news coming out of Cambridge, Mass, this week: Tolerx, a life sciences company, has reported they are in Phase 3 clinical trials for a new treatment of type 1 diabetes. If everything goes to plan, a representative of the company says, Tolerx could launch the first-ever offering approved by the FDA to treat the cause of type 1 diabetes. Pretty cool!…Read more »
Curious about what’s happening in the diabetes industry and research community? Or maybe (like me) you think that you already know what’s going on… Well, get ready for a concise and extremely entertaining exposé of the current status of diabetes care and research towards a cure.
The title is Diabetes Rising, the new “epic book” coming out in January 2010 by award-winning investigative journalist Dan Hurley, a type 1 diabetic himself. As the publicist explains:…
My mom’s been complaining that my latest posts have been too long. So I’m attempting to keep this one brief — despite the humongously eventful week I have behind me.
Extremely Brief Notes on Health 2.0
The second annual Health 2.0 Conference here in San Francisco was huge, up to nearly a thousand attendees from just half as many last year. This event brings together people from all walks of healthcare and Web 2.0 health…
Catchy title, ay? This is what they chose to dub the set of cutting-edge diabetes research presentations at last month’s NYC Diabetes Research Institute (DRI) meeting.
If you like to keep up on the latest and greatest advancements, this is certainly some stuff you should know about. Of particular interest:
* Preserving Beta Cells – Jay Skyler, NIH Study Chairman and past ADA President
Remember, it’s the so-called “regulatory t-cells” that keep the autoreactive (self-attacking)…